» Articles » PMID: 26424758

Familial Gastric Cancers

Overview
Journal Oncologist
Specialty Oncology
Date 2015 Oct 2
PMID 26424758
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Although the majority of gastric carcinomas are sporadic, approximately 10% show familial aggregation, and a hereditary cause is determined in 1%-3% cases. Of these, hereditary diffuse gastric cancer is the most recognized predisposition syndrome. Although rare, the less commonly known syndromes also confer a markedly increased risk for development of gastric cancer. Identification and characterization of these syndromes require a multidisciplinary effort involving oncologists, surgeons, genetic counselors, biologists, and pathologists. This article reviews the molecular genetics, clinical and pathologic features, surveillance guidelines, and preventive measures of common and less common hereditary gastric cancer predisposition syndromes.

Citing Articles

Current advances and challenges in Managing Hereditary Diffuse Gastric Cancer (HDGC): a narrative review.

van der Sluis L, van Dieren J, van der Post R, Bisseling T Hered Cancer Clin Pract. 2024; 22(1):21.

PMID: 39379994 PMC: 11462652. DOI: 10.1186/s13053-024-00293-5.


Risk of Esophageal and Gastric Cancer in Patients with Type 2 Diabetes Receiving Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A National Analysis.

Ayoub M, Aibani R, Dodd T, Ceesay M, Bhinder M, Faris C Cancers (Basel). 2024; 16(18).

PMID: 39335195 PMC: 11430483. DOI: 10.3390/cancers16183224.


Environmental and Genetic Risk Factors for Gastric Cancer.

Shah D, Bentrem D Cancer Treat Res. 2024; 192:1-17.

PMID: 39212913 DOI: 10.1007/978-3-031-61238-1_1.


Dual primary gastric and colorectal cancer: The known hereditary causes and underlying mechanisms.

Azer S World J Gastrointest Oncol. 2024; 16(6):2264-2270.

PMID: 38994141 PMC: 11236243. DOI: 10.4251/wjgo.v16.i6.2264.


Roles of long non‑coding RNA SNHG16 in human digestive system cancer (Review).

Zhao L, Kan Y, Wang L, Pan J, Li Y, Zhu H Oncol Rep. 2024; 52(2).

PMID: 38940337 PMC: 11234248. DOI: 10.3892/or.2024.8765.


References
1.
Puig L, Marti R, Matias-Guiu X, Lecha M, Guix M . Gastric adenocarcinoma in a patient with xeroderma pigmentosum. Br J Dermatol. 1985; 113(5):632-3. DOI: 10.1111/j.1365-2133.1985.tb02394.x. View

2.
Wu T, Kornacki S, Rashid A, Yardley J, Hamilton S . Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis. Am J Surg Pathol. 1998; 22(3):293-8. DOI: 10.1097/00000478-199803000-00003. View

3.
Miyoshi Y, Ando H, Nagase H, Nishisho I, Horii A, Miki Y . Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci U S A. 1992; 89(10):4452-6. PMC: 49100. DOI: 10.1073/pnas.89.10.4452. View

4.
Iwama T, Mishima Y, Utsunomiya J . The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment. Ann Surg. 1993; 217(2):101-8. PMC: 1242747. DOI: 10.1097/00000658-199302000-00002. View

5.
Bermejo J, Hemminki K . Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing. Ann Oncol. 2004; 15(12):1834-41. DOI: 10.1093/annonc/mdh474. View